These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23988396)
1. Life beyond Z11. Ahmed M; Douek M Breast; 2013 Dec; 22(6):1226-7. PubMed ID: 23988396 [TBL] [Abstract][Full Text] [Related]
2. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond. Gatzemeier W; Mann GB Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200 [TBL] [Abstract][Full Text] [Related]
3. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011. Krishnan MS; Recht A; Bellon JR; Punglia RS Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762 [TBL] [Abstract][Full Text] [Related]
4. Is regional nodes radiotherapy an alternative to surgery? Offersen BV; Nielsen HM; Overgaard M; Overgaard J Breast; 2013 Aug; 22 Suppl 2():S118-28. PubMed ID: 24074772 [TBL] [Abstract][Full Text] [Related]
5. [Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria]. Roosen A; Lousquy R; Bricou A; Delpech Y; Selz J; Le Maignan C; Bousquet G; Winterman S; Zelek L; Barranger E Gynecol Obstet Fertil; 2014 Jun; 42(6):409-14. PubMed ID: 24861437 [TBL] [Abstract][Full Text] [Related]
6. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J; Polgár C; Péley G; Németh G Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099 [TBL] [Abstract][Full Text] [Related]
7. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Yegiyants S; Romero LM; Haigh PI; DiFronzo LA Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977 [TBL] [Abstract][Full Text] [Related]
8. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study. Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432 [TBL] [Abstract][Full Text] [Related]
9. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
10. Are the Conclusions of Z11 Relevant to Community Practice? Jones GC; Dong T; Simone CB; Stinson S Clin Breast Cancer; 2015 Aug; 15(4):285-8. PubMed ID: 25659905 [TBL] [Abstract][Full Text] [Related]
11. Management of the axilla. Amersi F; Giuliano AE Hematol Oncol Clin North Am; 2013 Aug; 27(4):687-702, vii. PubMed ID: 23915739 [TBL] [Abstract][Full Text] [Related]
12. The evolving role of axillary lymph node dissection in the modern era of breast cancer management. Barry JM; Weber WP; Sacchini V Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434 [TBL] [Abstract][Full Text] [Related]
13. Can radiotherapy replace axillary dissection for patients with positive sentinel nodes? Recht A Breast Dis; 2010; 31(2):91-7. PubMed ID: 21368371 [TBL] [Abstract][Full Text] [Related]
14. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
15. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes. Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810 [TBL] [Abstract][Full Text] [Related]
16. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer? Joyce DP; Solon JG; Prichard RS; Power C; Hill AD Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798 [TBL] [Abstract][Full Text] [Related]
17. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Samphao S; Eremin JM; El-Sheemy M; Eremin O Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650 [TBL] [Abstract][Full Text] [Related]
18. Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial. Tseng J; Alban RF; Siegel E; Chung A; Giuliano AE; Amersi FF Breast J; 2021 Mar; 27(3):216-221. PubMed ID: 33586201 [TBL] [Abstract][Full Text] [Related]
19. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043 [TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node treatment in breast cancer: an update. Williams PA; Suggs J; Mangana SH J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]